Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Shares Shorted: Short Interest Down 50.2% in October

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the recipient of a large decline in short interest in October. As of October 15th, there was short interest totaling 82,052 shares, a decline of 50.2% from the September 30th total of 164,782 shares. Based on an average daily trading volume, of 94,563 shares, the days-to-cover ratio is currently 0.9 days. Approximately 1.3% of the company’s stock are short sold.

Creative Medical Technology Trading Down 3.4%

Shares of Creative Medical Technology stock traded down $0.02 during trading on Friday, hitting $0.66. 87,006 shares of the stock were exchanged, compared to its average volume of 100,397. The stock has a market capitalization of $4.32 million, a price-to-earnings ratio of -0.32 and a beta of 2.06. The company has a fifty day moving average price of $0.93 and a 200-day moving average price of $1.57. Creative Medical Technology has a 1-year low of $0.62 and a 1-year high of $4.72.

Creative Medical Technology (NASDAQ:CELZ) last posted its earnings results on Friday, August 7th. The company reported ($0.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.02). Equities research analysts forecast that Creative Medical Technology will post -1.18 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on CELZ shares. Weiss Ratings cut Creative Medical Technology from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, September 24th. Wall Street Zen upgraded Creative Medical Technology from a “sell” rating to a “hold” rating in a report on Saturday, September 12th. Finally, Roth Capital reiterated a “buy” rating on shares of Creative Medical Technology in a report on Thursday, August 20th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc is a biotechnology company focused on developing regenerative medicine and cellular therapies. Its research programs are designed to use stem cells and other biological approaches to address conditions for which existing treatment options may be limited.

The company has developed and investigated therapies based on autologous stem cells, meaning cells collected from and administered back to the same patient. Its programs have included CaverStem, a regenerative treatment candidate for erectile dysfunction, as well as investigational platforms such as FemCelz for female sexual dysfunction and ImmCelz, an immune-modulating cellular therapy platform.